newYou can listen to Fox’s news articles!
Weight loss drugs Market researchers predict that global demand for drug therapy could reach $150 billion by 2035, making its popularity continuing to grow.
GLP-1 agonists containing semaglutides such as Ozempic, Wegovy, Munjaro and Zepbound, such as semaglutides, are intended to be treated Type 2 diabetes and obese.
However, recent studies link these medications to additional benefits recommended by physicians for patients with increasing numbers, such as reducing the risk of heart disease and dementia.
Scientists may have discovered why pounds return after losing weight
Still, a recent Yale study found that only 3% of eligible adults received a prescription.
Should I take weight loss medication?
Most adults People who have obesity They are excellent candidates for these drugs, according to Dr. John Anderson, an internist and diabetes expert at Frist Clinic in Nashville, Tennessee.
Most adults with obesity are good candidates for these drugs, doctors told Fox News Digital. (istock)
“But the most important group we really want to deal with are patients who have obesity alongside other comorbidities such as type 2 diabetes and hypertension. Obstructive sleep apnea Anderson, who is also a board member of the Diabetes Guidance Council, told Fox News Digital.
“Anyone who wants to lose weight when obese is a good candidate, but from a healthcare perspective I am most concerned about this high-risk patient population.”
Direct comparison of Zepbound and Wegovy to get weight loss results
To qualify for weight loss medication, patients first work with their doctor to work with diet, exercise, sleep and Stress managementaccording to Dr. Michael Aziz, a board-certified board-certified physician and regenerative medicine expert based in New York City.
“A healthy, balanced diet with plenty of vegetables and low-sugar fruits should be the first step in weight loss,” he told Fox News Digital.
“However, some people are unable to lose weight despite their best efforts. This can be related to injuries and slow metabolism that prevent them from exercising.”
“Treating obesity early can prevent the progression of the disease.”
Insurance payments Weight loss drugs According to Aziz, if a patient’s body mass index is above 27.
(According to the National Institutes of Health, patients are considered obese if their BMI is 25-29.9, if the number is above 30.)
Beyond the high-risk group, Anderson said he wanted to see these drugs become “available and affordable” for the majority of patients affected by obesity.
GLP-1 agonists containing semaglutides such as Ozempic, Wegovy, Mounjaro and Zepbound are intended to treat type 2 diabetes and obesity. (Michael Siluk/UCG/Universal Images Group Getty Images)
“Treating obesity early can prevent the disease from progressing,” he said. “GLP-1 has been shown to reduce the progression from pre-diabetes to type 2 diabetes by 94%, significantly reducing the risk of majors. Cardiovascular events. ”
“Obesity is associated with 200 comorbidities, including heart disease, kidney disease, and 40% of all cancers, so it’s important to deal with the disease early.”
Doctors warn of “three contact” of chronic illnesses that are plaguing Americans after Maha’s report
According to Board-certified obese Dr. Wiljon Bertre, patients do not need to benefit from GLP-1 medications to lose weight. Metabolic Surgeon Founder of Beltre Bariatrics in Orlando, Florida.
“I also agree that patients with low levels of obesity (BMI below 30) can benefit greatly from these medications,” he told Fox News Digital.
“In fact, these patients may turn out to be good candidates for GLP-1 because they lose weight faster and appear to notice changes almost immediately.”
Benefits beyond obesity and diabetes
Several ongoing studies have investigated the use of weight loss medications to treat a variety of conditions, including alcoholism and addiction. Alzheimer’s disease and dementiaAnderson said hepatic disease.
“The mechanism behind these drug therapy is to empty the stomach and make it feel longer, but there is also feedback in the centre of the appetite in the hypothalamus in the brain, which will eliminate food noise,” he said.
“The most important group we really want to deal with are patients who suffer from obesity along with other comorbidities, including type 2 diabetes, hypertension, obstructive sleep apnea and serious osteoarthritis,” the doctor told Fox News Digital. (istock)
“Experts across the country are finding that it appears to reduce patients’ alcohol cravings, their compensation centres are off. Desire for alcohol. ”
While further research is needed to confirm this effect, Anderson said these drugs could be “life-changing” for potentially fighting addictions.
Weight loss drugs can also be useful for common medical issues, research finds
Aziz noted that GLP-1 drugs have also been shown to reduce the risk of both Heart attack and stroke 20%.
“They also help reverse the fatty liver and improve sleep apnea,” he added.
Risks and Limitations
Diabetes and obesity drugs are widely known to cause Gastrointestinal problems Some patients report primarily nausea, vomiting, constipation, and diarrhea.
Click here to get the Fox News app
“Most of them happen when you’re doing dose escalation and the majority can get through it,” Anderson said. “This usually occurs early in the treatment and tapers over time.”
Those interested in weight loss medication should consult their doctor to investigate potential benefits and risks. (istock)
Patients with a family history of the medulla Thyroid cancer Experts say pancreatitis should avoid these drugs. Pregnant women are also advised not to take this medicine.
Some patients also report loss of muscle mass, thinning and falling hair, changes in mood, and other undesired results.
Click here to sign up for our health newsletter
“People need to understand that GLP-1 is not a magical solution to weight loss, but that one foot of a three-legged stool needs to be combined. Healthy eating habits And exercise,” Bertre said.
It is also important that patients understand that they cannot take these medications forever, doctors noted.
“People need to understand that GLP-1 is not a magic solution for weight loss, but one foot of a three-legged stool.”
However, many physicians report that patient benefits outweigh potential side effects.
“The important thing is that many patients have been experiencing significant weight loss and are now able to participate in activities for the first time over the years: ice skating, walking, cancelling knee replacements, falling blood pressure medication,” Anderson noted.
Visit us for more health articles www.foxnews.com/health
Those interested in weight loss medication should consult their doctor to investigate potential benefits and risks.
